Sanofi’s Sarclisa cuts death risk in mutiple myeloma
The Phase III IKEMA trial hit its primary endpoint
Read More
Tag: IKEMA
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
